Charles River Labs Intl buy The Goldman Sachs Group, Inc.
Start price
06.06.24
/
50%
€199.65
Target price
06.06.25
€266.42
Performance (%)
-36.41%
End price
07.06.25
€126.95
Summary
This prediction ended on 07.06.25 with a price of €126.95. The BUY prediction by The_Goldman_Sachs_Gr for Charles River Labs Intl performed very badly with a performance of -36.41%. The_Goldman_Sachs_Gr has a follow-up prediction for Charles River Labs Intl where he still thinks Charles River Labs Intl is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | -0.091% | -0.091% | -6.395% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $290.00 price target on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€159.40
23.01.25
23.01.25
€182.70
23.01.26
23.01.26
3.76%
18.12.25
18.12.25
